The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation

An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Reduces Tumor Burden and Metastasis in a Preclinical Model of Ovarian Cancer Metastasis

(2015) Marion Zillhardt et al.   NEOPLASIA

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

(2011) M. Zillhardt et al.   CLINICAL CANCER RESEARCH

Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis

(2011) Shuyang Sun et al.   INTERNATIONAL JOURNAL OF CANCER

Breast Cancer-Derived Bone Metastasis Can Be Effectively Reduced through Specific c-MET Inhibitor Tivantinib (ARQ 197) and shRNA c-MET Knockdown

(2011) S. Previdi et al.   MOLECULAR CANCER THERAPEUTICS

Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth

(2011) F. M. Yakes et al.   MOLECULAR CANCER THERAPEUTICS

Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and β-catenin/Wnt pathways

(2010) Sara Previdi et al.   EUROPEAN JOURNAL OF CANCER

Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells

(2010) Prakash K. Rao et al.   FASEB JOURNAL

Inhibition of rhabdomyosarcoma's metastatic behavior through downregulation of MET receptor signaling.

(2010) Ewa Lukasiewicz et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Regulation of Expression of Stromal-Derived Factor-1 Receptors: CXCR4 and CXCR7 in Human Rhabdomyosarcomas

(2010) M. Tarnowski et al.   MOLECULAR CANCER RESEARCH

The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma

(2009) T. Y. Seiwert et al.   CANCER RESEARCH

Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of theMEToncogene

(2009) Simone Merlin et al.   CANCER SCIENCE

c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro

(2009) Sheng-Hua Chu et al.   JOURNAL OF NEURO-ONCOLOGY

The Met tyrosine kinase receptor in development and cancer

(2008) Alessandra Gentile et al.   CANCER AND METASTASIS REVIEWS

Alveolar rhabdomyosarcoma: Is the cell of origin a mesenchymal stem cell?

(2008) Elizabeth Charytonowicz et al.   CANCER LETTERS

Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations

(2008) Y.-X. Ren et al.   CANCER RESEARCH

Frzb, a Secreted Wnt Antagonist, Decreases Growth and Invasiveness of Fibrosarcoma Cells Associated with Inhibition of Met Signaling

(2008) Y. Guo et al.   CANCER RESEARCH

Clinical Significance of CXC Chemokine Receptor-4 and c-Met in Childhood Rhabdomyosarcoma

(2008) F. Diomedi-Camassei et al.   CLINICAL CANCER RESEARCH

The biological role of HGF-MET axis in tumor growth and development of metastasis

(2007) Ewa Lesko   Frontiers in Bioscience-Landmark